Exchange Rates 2011

Return to Exchange Rates

Table of Contents

  1. January 2011
  2. February 2011
  3. March 2011
  4. April 2011
  5. May 2011
  6. June 2011
  7. July 2011
  8. August 2011
  9. September 2011
  10. October 2011
  11. November 2011
  12. December 2011

January 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2010
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
Dec 2010 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between June 2010 to June 2011
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
June 2010 1.53704167 1.53704167 1.53704167 0.15618056 0.97811111 1.94547222 1.09052778
July 2010 1.53464722 1.53464722 1.53464722 0.15558889 0.97923889 1.92763611 1.08736389
Aug 2010 1.53022778 1.53022778 1.53022778 0.15493333 0.97923611 1.90723611 1.08333056
Sep 2010 1.52508056 1.52508056 1.52508056 0.15419722 0.97935000 1.88739167 1.07974167
Oct 2010 1.52022778 1.52022778 1.52022778 0.15348056 0.98001667 1.86940000 1.07821389
Nov 2010 1.51575556 1.51575556 1.51575556 0.15290556 0.98165000 1.85318611 1.07745556
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722

February 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2010
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
Dec 2010 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between July 2010 to July 2011
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
July 2010 1.53464722 1.53464722 1.53464722 0.15558889 0.97923889 1.92763611 1.08736389
Aug 2010 1.53022778 1.53022778 1.53022778 0.15493333 0.97923611 1.90723611 1.08333056
Sep 2010 1.52508056 1.52508056 1.52508056 0.15419722 0.97935000 1.88739167 1.07974167
Oct 2010 1.52022778 1.52022778 1.52022778 0.15348056 0.98001667 1.86940000 1.07821389
Nov 2010 1.51575556 1.51575556 1.51575556 0.15290556 0.98165000 1.85318611 1.07745556
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778

March 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2010 will be used in the review of prices for existing medicines in the first half of 2010.

The international prices of an existing drug product for the period January to June 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2010
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
Dec 2010 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Apr 2007, the exchange rates used are Apr 2007 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between August 2010 to August 2011
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Aug 2010 1.53022778 1.53022778 1.53022778 0.15493333 0.97923611 1.90723611 1.08333056
Sep 2010 1.52508056 1.52508056 1.52508056 0.15419722 0.97935000 1.88739167 1.07974167
Oct 2010 1.52022778 1.52022778 1.52022778 0.15348056 0.98001667 1.86940000 1.07821389
Nov 2010 1.51575556 1.51575556 1.51575556 0.15290556 0.98165000 1.85318611 1.07745556
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222

April 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2010 will be used in the review of prices for existing medicines in the second half of 2010.

The international prices of an existing drug product for the period January to December 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2010
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
Dec 2010 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Aug 2010, the exchange rates used are Aug 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between August 2010 to September 2011
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Aug 2010 1.53022778 1.53022778 1.53022778 0.15493333 0.97923611 1.90723611 1.08333056
Sep 2010 1.52508056 1.52508056 1.52508056 0.15419722 0.97935000 1.88739167 1.07974167
Oct 2010 1.52022778 1.52022778 1.52022778 0.15348056 0.98001667 1.86940000 1.07821389
Nov 2010 1.51575556 1.51575556 1.51575556 0.15290556 0.98165000 1.85318611 1.07745556
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500

May 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2010 will be used in the review of prices for existing medicines in the second half of 2010.

The international prices of an existing drug product for the period January to December 2010 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2010
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
Dec 2010 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Aug 2010, the exchange rates used are Aug 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between August 2010 to September 2011
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Sep 2010 1.52508056 1.52508056 1.52508056 0.15419722 0.97935000 1.88739167 1.07974167
Oct 2010 1.52022778 1.52022778 1.52022778 0.15348056 0.98001667 1.86940000 1.07821389
Nov 2010 1.51575556 1.51575556 1.51575556 0.15290556 0.98165000 1.85318611 1.07745556
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278

June 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2011 will be used in the review of prices for existing medicines in the first half of 2011.

The international prices of an existing drug product for the period January to June 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2011
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
June 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2010, the exchange rates used are Dec 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between August 2010 to September 2011
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Oct 2010 1.52022778 1.52022778 1.52022778 0.15348056 0.98001667 1.86940000 1.07821389
Nov 2010 1.51575556 1.51575556 1.51575556 0.15290556 0.98165000 1.85318611 1.07745556
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278
Nov 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444

July 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2011 will be used in the review of prices for existing medicines in the first half of 2011.

The international prices of an existing drug product for the period January to June 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2011
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
June 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2010, the exchange rates used are Dec 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between November 2010 to December 2011
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Nov 2010 1.51575556 1.51575556 1.51575556 0.15290556 0.98165000 1.85318611 1.07745556
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278
Nov 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444
Dec 2011 1.46921667 1.46921667 1.46921667 0.14923611 1.03313056 1.69646389 1.07295000

August 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2011 will be used in the review of prices for existing medicines in the first half of 2011.

The international prices of an existing drug product for the period January to June 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2011
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
June 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2010, the exchange rates used are Dec 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between December 2010 to January 2012
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Dec 2010 1.51281389 1.51281389 1.51281389 0.15245833 0.98498611 1.83811667 1.07724444
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278
Nov 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444
Dec 2011 1.46921667 1.46921667 1.46921667 0.14923611 1.03313056 1.69646389 1.07295000
Jan 2012 1.46465556 1.46465556 1.46465556 0.14885000 1.04118611 1.68598889 1.07096111

September 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2011 will be used in the review of prices for existing medicines in the first half of 2011.

The international prices of an existing drug product for the period January to June 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2011
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
June 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2010, the exchange rates used are Dec 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between January 2011 to February 2012
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Jan 2011 1.51006389 1.51006389 1.51006389 0.15212222 0.98841111 1.82429444 1.07677778
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278
Nov 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444
Dec 2011 1.46921667 1.46921667 1.46921667 0.14923611 1.03313056 1.69646389 1.07295000
Jan 2012 1.46465556 1.46465556 1.46465556 0.14885000 1.04118611 1.68598889 1.07096111
Feb 2012 1.46078889 1.46078889 1.46078889 0.14863889 1.04649444 1.67708056 1.06941389

October 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2011 will be used in the review of prices for existing medicines in the first half of 2011.

The international prices of an existing drug product for the period January to June 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2011
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
June 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2010, the exchange rates used are Dec 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between February 2011 to March 2012
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Feb 2011 1.50801389 1.50801389 1.50801389 0.15192500 0.99305000 1.81153889 1.07699167
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278
Nov 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444
Dec 2011 1.46921667 1.46921667 1.46921667 0.14923611 1.03313056 1.69646389 1.07295000
Jan 2012 1.46465556 1.46465556 1.46465556 0.14885000 1.04118611 1.68598889 1.07096111
Feb 2012 1.46078889 1.46078889 1.46078889 0.14863889 1.04649444 1.67708056 1.06941389
Mar 2012 1.45610000 1.45610000 1.45610000 0.14848611 1.04934722 1.66634722 1.06483056

November 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2011 will be used in the review of prices for existing medicines in the first half of 2011.

The international prices of an existing drug product for the period January to June 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending June 2011
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
June 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2010, the exchange rates used are Dec 2010 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between March 2011 to April 2012
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
Mar 2011 1.50875833 1.50875833 1.50875833 0.15195556 0.99916667 1.80100833 1.07818056
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278
Nov 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444
Dec 2011 1.46921667 1.46921667 1.46921667 0.14923611 1.03313056 1.69646389 1.07295000
Jan 2012 1.46465556 1.46465556 1.46465556 0.14885000 1.04118611 1.68598889 1.07096111
Feb 2012 1.46078889 1.46078889 1.46078889 0.14863889 1.04649444 1.67708056 1.06941389
Mar 2012 1.45610000 1.45610000 1.45610000 0.14848611 1.04934722 1.66634722 1.06483056
April 2012 1.45156111 1.45156111 1.45156111 0.14845833 1.05232222 1.65950833 1.05948611

December 2011

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2011 will be used in the review of prices for existing medicines in the second half of 2011.

The international prices of an existing drug product for the period January to December 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

36 Month Average Exchange Rates Ending December 2011
Period
Ending
France
(Euro)
Germany
(Euro)
Italy
(Euro)
Sweden Switzerland United Kingdom United States
Dec 2011 1.44276944 1.44276944 1.44276944 0.14832778 1.05275000 1.65286944 1.05363333

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

Average Exchange Rates for New Drug Products Introduced Between April 2011 to May 2012
Month of Introduction France (Euro) Germany (Euro) Italy (Euro) Sweden Switzerland United Kingdom United States
April 2011 1.50767778 1.50767778 1.50767778 0.15183056 1.00379167 1.79027778 1.07945000
May 2011 1.50414444 1.50414444 1.50414444 0.15161389 1.00825833 1.77774167 1.07957778
June 2011 1.49972222 1.49972222 1.49972222 0.15137222 1.01155833 1.76606667 1.07909722
July 2011 1.49624444 1.49624444 1.49624444 0.15126389 1.01497778 1.75581389 1.07877778
Aug 2011 1.49106389 1.49106389 1.49106389 0.15094444 1.01701944 1.74391389 1.07807222
Sept 2011 1.48516944 1.48516944 1.48516944 0.15050000 1.01889444 1.73168611 1.07652500
Oct 2011 1.48053056 1.48053056 1.48053056 0.15016944 1.02310556 1.72105000 1.07565278
Nov 2011 1.47565833 1.47565833 1.47565833 0.14977222 1.02817222 1.70951944 1.07454444
Dec 2011 1.46921667 1.46921667 1.46921667 0.14923611 1.03313056 1.69646389 1.07295000
Jan 2012 1.46465556 1.46465556 1.46465556 0.14885000 1.04118611 1.68598889 1.07096111
Feb 2012 1.46078889 1.46078889 1.46078889 0.14863889 1.04649444 1.67708056 1.06941389
Mar 2012 1.45610000 1.45610000 1.45610000 0.14848611 1.04934722 1.66634722 1.06483056
April 2012 1.45156111 1.45156111 1.45156111 0.14845833 1.05232222 1.65950833 1.05948611
May 2012 1.44276944 1.44276944 1.44276944 0.14832778 1.05275000 1.65286944 1.05363333
Date modified: